Anthony Dorling
About
In The Last Decade
Anthony Dorling
142 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 113
- Surgery 1.9k
- Immunology 1.1k
- Transplantation 849
- Genetics 691
- Molecular Biology 507
Countries citing papers authored by Anthony Dorling
This map shows the geographic impact of Anthony Dorling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Dorling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Dorling more than expected).
Fields of papers citing papers by Anthony Dorling
This network shows the impact of papers produced by Anthony Dorling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Dorling. The network helps show where Anthony Dorling may publish in the future.
Co-authorship network of co-authors of Anthony Dorling
This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Dorling. A scholar is included among the top collaborators of Anthony Dorling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Dorling. Anthony Dorling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 11 | |
| 3 | 68 | |
| 4 | 12 | |
| 5 | 31 | |
| 6 | RISK FACTORS ASSOCIATED WITH ANTIBODY-MEDIATED REJECTION IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION | 1 |
| 7 | LONG-TERM OUTCOME OF HLA-ANTIBODY AND ABO INCOMPATIBLE KIDNEY TRANSPLANTATION | 3 |
| 8 | 3 | |
| 9 | Chronic Antibody-Mediated Rejection: B-Cell Dependent Alloreactive IFN gamma-Producing CD4+ T Cells Could Be Used as a Biomarker To Determine Responsiveness to Therapy | 1 |
| 10 | 1 | |
| 11 | SUCCESSFUL OUTCOMES AFTER MINIMISING ANTIBODY MODULATION IN BLOOD GROUP INCOMPATIBLE KIDNEY TRANSPLANTATION | 3 |
| 12 | 92 | |
| 13 | 39 | |
| 14 | 14 | |
| 15 | 6 | |
| 16 | 7 | |
| 17 | 79 | |
| 18 | 5 | |
| 19 | 43 | |
| 20 | 106 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.